Study of Theliatinib (HMPL-309) in Patients With Advanced Solid Tumor
Clinical trial NCT02601248 · COMPLETED
Trial details
- NCT number
- NCT02601248
- Sponsor
- Hutchison Medipharma Limited
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-01
- Primary completion
- 2016-02-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.